Veristat, LLC

Veristat is a science-first, full-service clinical research organization (CRO) and consultancy that integrates strategic planning, regulatory affairs, and clinical trial execution. The company specializes in helping pharmaceutical, biotechnology, and medical device companies navigate complex development programs, particularly in rare diseases, oncology, and advanced therapies (cell and gene therapy). With over 30 years of experience, Veristat provides end-to-end support from early-stage development through regulatory submission and commercialization. The company is known for its expertise in managing complex regulatory pathways and has supported over 100 successful regulatory approvals globally. Veristat continues to expand its footprint and capabilities, including recent investments in AI-driven biostatistics and the acquisition of specialized regulatory and medical writing businesses.